2J. J. Schuitmaker, P. Baas, H. L. van-Leengoed et al.. Photodynamic therapy: a promising new modality for the treatment of caneer[J]. J. Photochem. Photobiol. B, 1996, 34(1) : 3-12.
3R. Bachor, E. Reich, K. Miller et al.. Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines[J]. Urol. Res. , 1995, 23(3): 151-156.
4A. Stenzl. Can we still afford bladder cancer? [J]. Curr. Opin. Urol. , Z008, 18(5): 488-492.
5P. Jichlinski, G. Wagnieres, M. Forrer et al.. Clinical assessment of fluorescence eytoscopy during transurethral bladder resection in superficial bladder cancer[J]. Urol. Res., 1997, 25(1): S3-6.
6J. Schmidbauer, F. Witjes, N. Sehmeller et al.. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy[J]. J. Urol., 2004, 171:135.
7H. B. Grossman, L. Gomella, Y. Fradet et al.. A phase m, multicenter comparison of hexaminolevulinate fluorescence cystoseopy and white light eystoseopy for the detection of superficial papillary lesions in patients with bladder eancer[J]. J. Urol., 2007, 178(1): 62-67.
8T. Uchibayashi, K. Koshida, K. Kunimi et al.. Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder[J]. Br. J. Cancer, 1995, 71(3): 625-628.
9M. Kriegmair, R. Waidelich, W. Lumper et al.. Integral photodynamic treatment of refractory superficial bladder cancer [J]. J. Urol. , 1995, 154(4): 1339-1341.
10U. O. Nseyo, B. Shumaker, E. A. Klein et al.. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder[J]. J. Urol., 1998, 140(1): 39-44.
